{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT04326985",
      "OrgStudyIdInfo": {
        "OrgStudyId": "OA MSC Study protocol v 1.4"
      },
      "Organization": {
        "OrgFullName": "Chinese University of Hong Kong",
        "OrgClass": "OTHER"
      },
      "BriefTitle": "RCT Mesenchymal Stem Cells Versus Hyaluronic Acid in OA Knee):",
      "OfficialTitle": "A Randomized Control Clinical Trial to Evaluate the Efficacy of Intra-articular Injections of Mesenchymal Stem Cells Versus Hyaluronic Acid in Patients Affected by Osteoarthritis of the Knee",
      "Acronym": "MSC"
    },
    "StatusModule": {
      "StatusVerifiedDate": "May 2020",
      "OverallStatus": "Completed",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "January 31, 2015",
        "StartDateType": "Actual"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "January 30, 2019",
        "PrimaryCompletionDateType": "Actual"
      },
      "CompletionDateStruct": {
        "CompletionDate": "February 28, 2019",
        "CompletionDateType": "Actual"
      },
      "StudyFirstSubmitDate": "March 27, 2020",
      "StudyFirstSubmitQCDate": "March 27, 2020",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "March 30, 2020",
        "StudyFirstPostDateType": "Actual"
      },
      "LastUpdateSubmitDate": "May 14, 2020",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "May 18, 2020",
        "LastUpdatePostDateType": "Actual"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Principal Investigator",
        "ResponsiblePartyInvestigatorFullName": "Dr. Ho Ki Wai",
        "ResponsiblePartyInvestigatorTitle": "Clinical Professional Consultant",
        "ResponsiblePartyInvestigatorAffiliation": "Chinese University of Hong Kong"
      },
      "LeadSponsor": {
        "LeadSponsorName": "Chinese University of Hong Kong",
        "LeadSponsorClass": "OTHER"
      }
    },
    "OversightModule": {
      "OversightHasDMC": "No",
      "IsFDARegulatedDrug": "No",
      "IsFDARegulatedDevice": "No",
      "IsUSExport": "No"
    },
    "DescriptionModule": {
      "BriefSummary": "The purpose of this study is to evaluate the therapeutic effect of adult autologous mesenchymal stem cells (abbreviated as MSCs) in patients with osteoarthritic knee and compare to intra articular injection of Synvisc-One.",
      "DetailedDescription": "Study Participants:\n\nThis study will involve patients affected by osteoarthritis who comply with the inclusion and exclusion criteria. 30 patients, between the age of 18 and <65, will be enrolled in the study and randomized into three groups to receive either an injection of MSCs, hyaluronic acid (HA) or no injection.\n\nType of Study: This is a randomized control study.\n\nTreatment method: Each patient will randomly be assigned to one of the following treatment groups:\n\nGroup A) Mesenchymal stem cells (MSCs) Group B) Hyaluronic acid (HA) Group C) No injection\n\nTreatment:\n\nGroup A) Autologous Mesenchymal Stem Cells Treatment (MSCs) The MSCs treatment group patients will receive an intra-articular injection of a mesenchymal stem cell (MSCs) suspension in the affected knee.\n\nThe treatment will be carried out after the patient has received a blood test and clinically evaluated at T0.\n\nT0: Beginning of the study, blood test and bone marrow aspiration. T30: Intra-articular injection of MSCs T44: Adverse events follow up 2 weeks after intra-articular injection (by phone)\n\nGroup B) Hyaluronic acid (HA) The patient will be given a single intra-articular injection of hyaluronic acid sodium salt, Synvisc-One (TRB Chemedica Ltd.) The hyaluronic acid will be purchased for the patient from the manufacturer or from the pharmacy of the hospital.\n\nThe intra-articular injection will be carried out after the patient has received a clinical evaluation at T0.\n\nT0: Beginning of the study T30: Intra-articular injection of Synvisc-One (HA) T44: Adverse events follow up 2 weeks after intra-articular injection (by phone)"
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Osteoarthritis, Knee"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Early Phase 1"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "Randomized",
        "DesignInterventionModel": "Parallel Assignment",
        "DesignInterventionModelDescription": "Prospective Randomized Controlled Trial",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "None (Open Label)"
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "20",
        "EnrollmentType": "Actual"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "Autologous Mesenchymal Stem Cells Treatment (MSCs)",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "The MSCs treatment group patients will receive an intra-articular injection of a mesenchymal stem cell (MSCs) suspension in the affected knee.\n\nThe treatment will be carried out after the patient has received a blood test and clinically evaluated at T0.\n\nT0: Beginning of the study, blood test and bone marrow aspiration. T30: Intra-articular injection of MSCs T44: Adverse events follow up 2 weeks after intra-articular injection (by phone)",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: Autologous Mesenchymal Stem Cells Treatment (MSCs)"
              ]
            }
          },
          {
            "ArmGroupLabel": "Hyaluronic acid (HA)",
            "ArmGroupType": "Active Comparator",
            "ArmGroupDescription": "The patient will be given a single intra-articular injection of hyaluronic acid sodium salt, Synvisc-One (TRB Chemedica Ltd.) The hyaluronic acid will be purchased for the patient from the manufacturer or from the pharmacy of the hospital.The intra-articular injection will be carried out after the patient has received a clinical evaluation at T0.\n\nT0: Beginning of the study T30: Intra-articular injection of Synvisc-One (HA) T44: Adverse events follow up 2 weeks after intra-articular injection (by phone)",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Drug: Hyaluronic acid (HA)"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Biological",
            "InterventionName": "Autologous Mesenchymal Stem Cells Treatment (MSCs)",
            "InterventionDescription": "The MSCs treatment group patients will receive an intra-articular injection of a mesenchymal stem cell (MSCs) suspension in the affected knee.",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Autologous Mesenchymal Stem Cells Treatment (MSCs)"
              ]
            }
          },
          {
            "InterventionType": "Drug",
            "InterventionName": "Hyaluronic acid (HA)",
            "InterventionDescription": "The HA group patient will be given a single intra-articular injection of hyaluronic acid sodium salt, Synvisc-One (TRB Chemedica Ltd.)",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Hyaluronic acid (HA)"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "Knee Society Score",
            "PrimaryOutcomeDescription": "Clinical Questionnaire Assessment Tool. Score 80-100 = Excellent, Score 70-79 = Good, Score 60-69 = Fair, Score below 60 = Poor",
            "PrimaryOutcomeTimeFrame": "One year"
          },
          {
            "PrimaryOutcomeMeasure": "Knee Society Function Score",
            "PrimaryOutcomeDescription": "Clinical Questionnaire Assessment Tool. Score from 100 to -20. The higher the score, the better the knee function outcome.",
            "PrimaryOutcomeTimeFrame": "One year"
          },
          {
            "PrimaryOutcomeMeasure": "Magnetic resonance image (MRI) and X-ray assessment",
            "PrimaryOutcomeDescription": "Radiological assessment of the knee joint",
            "PrimaryOutcomeTimeFrame": "One year"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "Health related quality of life score (HRQoL) - SF36",
            "SecondaryOutcomeDescription": "Questionnaire Assessment",
            "SecondaryOutcomeTimeFrame": "One year"
          },
          {
            "SecondaryOutcomeMeasure": "Western Ontario and McMaster Osteoarthritis Index (WOMAC)",
            "SecondaryOutcomeDescription": "Questionnaire Assessment",
            "SecondaryOutcomeTimeFrame": "One year"
          },
          {
            "SecondaryOutcomeMeasure": "Visual Analogic Scale (VAS) pain evaluation",
            "SecondaryOutcomeDescription": "Questionnaire Assessment",
            "SecondaryOutcomeTimeFrame": "One year"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nMale and female subjects aged between 18 and < 65\nRadiological evidence of osteoarthritis with Kellgren and Lawrence grade 2 and 3\nPatients on a pain level equal to or higher than 5 on a VAS scale of 10\n\nExclusion Criteria:\n\nPrevious cases of alcoholism or drug abuse\nPregnancy and breast-feeding\nSerious pathologies such as carcinoma or autoimmune disease\nHypersensitivity toward Hyaluorinc Acid\nUndergoing steroid-based systemic therapy or interrupted since less than 1 month\nSignificant hematologic diseases\nMechanical instability, ligamentous laxity/deficiency or gross deformity",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "18 Years",
      "MaximumAge": "65 Years",
      "StdAgeList": {
        "StdAge": [
          "Adult",
          "Older Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "Department of Orthopaedics & Traumatology",
            "LocationCity": "Hong Kong",
            "LocationCountry": "Hong Kong"
          }
        ]
      }
    },
    "IPDSharingStatementModule": {
      "IPDSharing": "Undecided"
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000010003",
            "ConditionMeshTerm": "Osteoarthritis"
          },
          {
            "ConditionMeshId": "D000020370",
            "ConditionMeshTerm": "Osteoarthritis, Knee"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000001168",
            "ConditionAncestorTerm": "Arthritis"
          },
          {
            "ConditionAncestorId": "D000007592",
            "ConditionAncestorTerm": "Joint Diseases"
          },
          {
            "ConditionAncestorId": "D000009140",
            "ConditionAncestorTerm": "Musculoskeletal Diseases"
          },
          {
            "ConditionAncestorId": "D000012216",
            "ConditionAncestorTerm": "Rheumatic Diseases"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M12078",
            "ConditionBrowseLeafName": "Osteoarthritis",
            "ConditionBrowseLeafAsFound": "Osteoarthritis",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M21321",
            "ConditionBrowseLeafName": "Osteoarthritis, Knee",
            "ConditionBrowseLeafAsFound": "Osteoarthritis, Knee",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M3628",
            "ConditionBrowseLeafName": "Arthritis",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M9773",
            "ConditionBrowseLeafName": "Joint Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M11249",
            "ConditionBrowseLeafName": "Musculoskeletal Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M14197",
            "ConditionBrowseLeafName": "Rheumatic Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M5475",
            "ConditionBrowseLeafName": "Collagen Diseases",
            "ConditionBrowseLeafRelevance": "low"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC05",
            "ConditionBrowseBranchName": "Musculoskeletal Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC17",
            "ConditionBrowseBranchName": "Skin and Connective Tissue Diseases"
          }
        ]
      }
    },
    "InterventionBrowseModule": {
      "InterventionMeshList": {
        "InterventionMesh": [
          {
            "InterventionMeshId": "D000006820",
            "InterventionMeshTerm": "Hyaluronic Acid"
          }
        ]
      },
      "InterventionAncestorList": {
        "InterventionAncestor": [
          {
            "InterventionAncestorId": "D000000276",
            "InterventionAncestorTerm": "Adjuvants, Immunologic"
          },
          {
            "InterventionAncestorId": "D000007155",
            "InterventionAncestorTerm": "Immunologic Factors"
          },
          {
            "InterventionAncestorId": "D000045505",
            "InterventionAncestorTerm": "Physiological Effects of Drugs"
          },
          {
            "InterventionAncestorId": "D000055675",
            "InterventionAncestorTerm": "Viscosupplements"
          },
          {
            "InterventionAncestorId": "D000020011",
            "InterventionAncestorTerm": "Protective Agents"
          }
        ]
      },
      "InterventionBrowseLeafList": {
        "InterventionBrowseLeaf": [
          {
            "InterventionBrowseLeafId": "M9030",
            "InterventionBrowseLeafName": "Hyaluronic Acid",
            "InterventionBrowseLeafAsFound": "Ophthalmic",
            "InterventionBrowseLeafRelevance": "high"
          },
          {
            "InterventionBrowseLeafId": "M250495",
            "InterventionBrowseLeafName": "Hylan",
            "InterventionBrowseLeafRelevance": "low"
          },
          {
            "InterventionBrowseLeafId": "M2780",
            "InterventionBrowseLeafName": "Adjuvants, Immunologic",
            "InterventionBrowseLeafRelevance": "low"
          },
          {
            "InterventionBrowseLeafId": "M9353",
            "InterventionBrowseLeafName": "Immunologic Factors",
            "InterventionBrowseLeafRelevance": "low"
          },
          {
            "InterventionBrowseLeafId": "M27448",
            "InterventionBrowseLeafName": "Viscosupplements",
            "InterventionBrowseLeafRelevance": "low"
          },
          {
            "InterventionBrowseLeafId": "M21022",
            "InterventionBrowseLeafName": "Protective Agents",
            "InterventionBrowseLeafRelevance": "low"
          }
        ]
      },
      "InterventionBrowseBranchList": {
        "InterventionBrowseBranch": [
          {
            "InterventionBrowseBranchAbbrev": "All",
            "InterventionBrowseBranchName": "All Drugs and Chemicals"
          }
        ]
      }
    }
  }
}